Loading...
XSHE
002734
Market cap1.36bUSD
Feb 24, Last price  
19.85CNY
1Q
21.18%
Jan 2017
28.23%
IPO
289.98%
Name

Limin Group Co Ltd

Chart & Performance

D1W1MN
XSHE:002734 chart
P/E
115.07
P/S
2.21
EPS
0.17
Div Yield, %
1.26%
Shrs. gr., 5y
0.45%
Rev. gr., 5y
8.39%
Revenues
4.24b
+0.32%
488,660,700471,597,700518,436,400575,840,394610,664,631665,990,621757,952,977834,544,0511,160,424,6391,423,420,5201,519,182,0412,832,674,5774,388,047,8974,737,565,9855,016,359,9014,223,936,9644,237,402,851
Net income
81m
+31.11%
45,751,70060,068,40091,789,60064,697,31463,078,84852,440,45148,366,76667,439,600112,992,341137,323,646206,113,576321,894,664386,024,873306,922,328219,041,68862,051,82981,357,608
CFO
374m
-20.70%
48,095,00060,941,50075,471,30058,024,49460,528,494102,822,61862,912,06791,238,821259,441,17073,063,987231,571,605196,965,174903,335,20759,597,931642,538,118471,387,889373,828,111
Dividend
May 28, 20250.25 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Limin Group Co., Ltd. researches, develops, manufactures, and markets fungicides and other pesticides in China. The company offers various pesticide technical materials and preparations, such as mancozeb, cymoxanil, fosetyl-aluminum, propineb, pyrimethanil, propiconazole, difenoconazole, chlorothalonil, thiacloprid, metham sodium, Zineb, etc. It sells its products in approximately 70 countries and regions. The company was formerly known as Limin Chemical Co., Ltd. and changed its name to Limin Group Co., Ltd. in January 2020. Limin Group Co., Ltd. is headquartered in Xinyi, China.
IPO date
Jan 27, 2015
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT